Healthcare & Pharma
Regulatory timeline
2026
2026
2026
2027
Sector pain points
Pharma sustainability leads describe their daily friction.
Quantifying real emissions of an API made in India and formulated in Belgium is a puzzle.
Without visibility on which products are most exposed and how to allocate the financial impact.
You have no standardized methodology to defend your numbers.
Each pharmacist fills their own spreadsheet.
Your team becomes a regulation translation service.
How Tapio helps
Five capabilities that turn API supply chains and regional permits into one workflow.
Track an API from source country to formulation and packaging. Scope 3 emissions calculated per molecule, per batch, per market.
Allocate financial liability per molecule. Spot the most exposed products and forecast your EPR contribution before it hits your P&L.
Compare your carbon intensity to Novo, GSK, Pfizer-class peers using a methodology you fully control and can defend in front of investors.
Pharmacy network reporting in one feed. Each pharmacist enters once, the head office sees the consolidated waste flows in real time.
Wallonia, Brussels and Flanders permits side-by-side. Same data, three regional formats, automated cross-checks.
Customer stories
“The Tapio platform centralizes all the information essential for calculating carbon footprints. That's a critical necessity when you federate a range of very different companies — and a relief for any sustainability lead.”
Julie Vanvolsem
Sustainability Manager — Univercells
Sector expertise
Tapio isn't just software. You work with carbon experts who understand your industry's regulations, emission hotspots and reduction levers — so you skip the generic playbook and act on what actually moves your numbers.
30-minute demo with a pharma sector expert. Bring your sites, we show you the platform.